Summary
A panel of 2 polyclonal and 7 monoclonal antibodies directed against cytokeratins was tested on cryostat and paraffin sections of 14 normal human liver biopsies using an immunoperoxidase procedure. The staining characteristics of hepatocytes and bile ducts are reported. On cryostat sections, monoclonal antibodies directed against individual cytokeratins no8 and no18 stained both bile ducts and hepatocytes, whereas monoclonals anti-cytokeratin no7 and no19 exclusively stained bile ducts. The potential use of these 4 monoclonal antibodies in liver histopathology is briefly discussed. Monoclonal antibody anti-type II cytokeratins and the polyclonal rabbit anti-human keratin stained only bile ducts on both cryostat and paraffin sections. Using monoclonal antibody CAM 5.2 on paraffin sections, both bile ducts and parenchyma were positive. An acinar gradient was apparent in that zone 1 hepatocytes were more intensely stained. Moreover, a rim of hepatocytes around terminal hepatic venules and adjacent to subhepatic veins showed more intense staining. The same gradient could be seen in some paraffin sections stained with the monoclonals anti-cytokeratin no18 and KL1, and the rabbit polyclonal anti-keratin “wide spectrum screening”. The gradient is interpreted as reflecting quantitative differences in keratin content between hepatocytes. Polyclonal rabbit anti-human keratin is proposed as the most reliable antibody for identification of bile ducts in paraffin sections. The usefulness of reliable bile duct staining in several pathological conditions is emphasized.
Similar content being viewed by others
References
Alagille D, Odièvre M (1978) Maladies du foie et des voies biliaires chez l'enfant. Flammarion Médecine Sciences, Paris, p 150
Biava CG (1964) Studies on cholestasis. A reevaluation of the fine structure of normal human bile canaliculi. Lab Invest 13:840–864
Butron Vila MM, Haot J, Desmet VJ (1984) Cholestatic features in focal nodular hyperplasia of the liver. Liver 4:387–395
Chedid A, Spellberg MA, De Beer RA (1974) Ultrastructural aspects of primary biliary cirrhosis and other types of cholestatic liver disease. Gastroenterology 67:858–869
Cooper D, Schermer A, Sun TT (1985) Biology of disease. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications and limitations. Lab Invest 52:243–256
Corson JM (1986) Keratin protein immunohistochemistry in surgical pathology practice. In: Sommers SC, Rosen PP, Fechner RE (eds) Pathology Annual. Appleton Century Crofts, Norwalk Connecticut
Dahms BB, Petrelli M, Wyllie R, Henoch MS, Halpin TC, Morrison S, Park MC, Tavill AS (1982) Arteriohepatic dysplasia in infancy and childhood: a longitudinal study of six patients. Hepatology 2:350–358
DeLellis RA, Bahn I, Mueller J, Kwan P, Cho S, Hull D, Reinhold R, Farvaz K, Kaplan M (1986) The use of keratin antibodies in the assessment of rejection in orthotopic liver transplants. Hepatology 6:1194 (abstract)
Denk H (1984) The intermediate filament cytoskeleton in neoplastic and non-neoplastic liver disorders. J Submicrosc Cytol 16:141–145
Denk H, Lackinger E (1986) Cytoskeleton in liver diseases. Sere Liver Dis 6:199–211
Denk H, Franke WW, Dragosics B, Zeiler I (1981) Pathology of cytoskeleton of liver cells: demonstration of Mallory bodies (alcoholic hyalin) in murine and human heptocytes by immunofluorescence microscopy using antibodies to cytokeratin polypeptides from hepatocytes. Hepatology 1:9–20
Denk H, Krepler R, Lackinger E, Artlieb U, Franke WW (1982) Immunological and biochemical characterization of the keratin-related component of Mallory bodies: a pathological pattern of hepatocytic cytokeratins. Liver 2:165–175
Franke WW, Weber K, Osborn M, Schmid E, Freudenstein C (1978) Antibody to prekeratin. Exp Cell Res 116:429–445
Franke WW, Schmid E, Kartenbeck J, Mayer D, Hacker HJ, Bannash P, Osborn M, Weber K, Denk H, Wanson J-C, Drochmans P (1979) Characterization of the intermediate-sized filaments in liver cells by immunofluorescence and electron microscopy. Biol Cellul 34:99–110
Franke WW, Denk H, Kalt R, Schmid E (1981) Biochemical and immunological identification of cytokeratin proteins present in hepatocytes of mammalian liver tissue. Exp Cell Res 131:299–318
Hazan R, Denk H, Franke WW, Lackinger E, Schiller DL (1986) Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody. Lab Invest 54:543–553
Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580
Krepler R, Denk H, Artlieb U, Fichtinger E, Davidovits A (1982) Antibodies to intermediate filament proteins as molecular markers in clinical tumor pathology. Differentiation of carcinomas by their reaction with different cytokeratin antibodies. Pathol Res Pract 175:212–226
Lane EB (1982) Monoclonal antibodies provide specific intramolecular markers for the study of epithelial tonofilament organization. J Cell Biol 92:665–673
Lane EB, Bartek J, Purkis PE, Leigh IM (1985) Keratin antigens in differentiating skin. Ann NY Acad Sci 455:241–258
Lazarides E (1980) Intermediate filaments as mechanical integrators of cellular space. Nature 283:249–256
Makin CA, Bobrow LG, Bodmer WF (1984) Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol 37:975–983
Mason DJ, Naiem M, Abdulaziz Z Nash JRG, Gatter KC, Stein H (1982) Immunohistochemical labelling of cryostat sections with monoclonal antibody. In: McMichael AJ, Fabre JW, eds. Monoclonal antibodies in clinical medicine. Academic Press, London, pp 632–635
Moll R, Franke WW, Schiller DA, Geiger B, Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11–24
Osborn M (1983) Intermediate filaments as histologic markers: an overview. J Invest Dermatol 81:104s-109s
Osborn M, Altmannsberger M, Debus E, Weber K (1984) Differentiation of the major human tumor groups using conventional and monoclonal antibodies specific for individual intermediate filament proteins. Ann NY Acad Sci 455:649–668
Osborn M, van Lessen G, Weber K, Klöppel G, Altmannsberger M (1986) Methods in laboratory investigation. Differential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides. Lab Invest 55:497–504
Schlegel R, Banks-Schlegel S, and Pinkus GS (1980) Immunohistochemical localization of keratin in normal human tissues. Lab Invest 42:91–96
Sciot R, Van Damme B, Desmet VJ (1986) Cholestatic features in hepatitis A. J Hepatol 3:172–181
Steinert PM (1975) The extraction and characterization of bovine epidermal alpha-keratin. Biochem J 149:39–48
Sternberger LA (1974) The unlabeled antibody enzyme method. Immunohistochemistry. Prentice Hall, Englewood Cliff NJ, pp 129–171
Sternlieb I (1965) Perinuclear filaments and microtubules in human hepatocytes and biliary epithelial cells. J Microsc (Paris) 4:551–558
Stosiek P, Karsten U, Kasper M (1985) Monoclonal anti-cytokeratin antibodies reveal bile duct origin of cirrhotic ductular proliferations (dp) case report. Virchows Arch [A] 407:233–235
Tolle HG, Weber K, Osborn M (1985) Microinjection of monoclonal antibodies specific for one intermediate filament protein in cells containing multiple keratins allow insight into the composition of particular 10 nm filaments. Eur J Cell Biol 38:234–244
Vanstapel MJ, Butron M, Desmet VJ (1984) Keratin immunohistochemistry in normal and pathological human liver. Hepatology 4:1037 (abstract)
Viac J, Reano A, Brochier J, Staquet MJ, Thivolet J (1983) Reactivity patterns of a monoclonal antikeratin antibody (KL1). J Invest Dermatol 81:351–354
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Eyken, P., Sciot, R., van Damme, B. et al. Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Vichows Archiv A Pathol Anat 412, 63–72 (1987). https://doi.org/10.1007/BF00750732
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00750732